Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Application values of mNGS

PROVIDER: PRJNA938262 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23606200_1.fastq.gz	Fastqsanger.gz
	SRR23606200_2.fastq.gz	Fastqsanger.gz
	SRR23606300_1.fastq.gz	Fastqsanger.gz
	SRR23606300_2.fastq.gz	Fastqsanger.gz
	SRR23606400_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 550

Similar Datasets

Harnessing Bronchoalveolar Lavage Metagenomics for Distinguishing Lung Cancer from Pulmonary Infectious Diseases

Project description:Recent progress in unbiased metagenomic next-generation sequencing (mNGS) allows simultaneous examination of microbial and host genetic material in a single test. Leveraging affordable bronchoalveolar lavage fluid (BALF) mNGS data, we employed machine learning to create a diagnostic approach distinguishing lung cancer from pulmonary infections, conditions prone to misdiagnosis in clinical settings. This prospective study analyzed BALF-mNGS data from lung cancer and pulmonary infection patients, delineating differences in DNA/RNA microbial composition, bacteriophage abundances, and host responses, including gene expression, transposable element levels, immune cell composition, and tumor fraction derived from copy number variation (CNV). Integrating these metrics into a host/microbe metagenomics-driven machine learning model (Model VI) demonstrated robustness, achieving an AUC of 0.87 (95% CI = 0.857-0.883), sensitivity = 73.8%, and specificity = 84.5% in the training cohort, and an AUC of 0.831 (95% CI = 0.819-0.843), sensitivity = 67.1%, and specificity = 94.4% in the validation cohort for distinguishing lung cancer from pulmonary infections. The application of a rule-in and rule-out strategy-based composite predictive model significantly enhances accuracy (ACC) in distinguishing between lung cancer and tuberculosis (ACC=0.913), fungal infection (ACC=0.955), and bacterial infection (ACC=0.836). These findings highlight the potential of cost-effective mNGS-based analysis as a valuable tool for early differentiation between lung cancer and pulmonary infections, offering significant benefits through a single comprehensive testing.

2024-01-08 | GSE252118 | GEO

metagenome

Project description:Application of mNGS in Urinary Tract Infection

| PRJNA1058149 | ENA

Project description:Application of mNGS in intractable infectious diseases

| PRJNA706470 | ENA

Appropriate local pH value boosting the efficacy of fibroblast growth factor to promote wound repair

Project description:To explore whether the application of FGF with different isoelectric points in wounds with different pH values, GelMA hydrogels with different pH values were prepared to maintain the wounds microenvironment with the same pH values, in which aFGF and bFGF were loaded as well.interferes with the healing process to different degrees,

2023-02-22 | GSE225505 | GEO

E-MTAB-6243

Project description:Transcriptional response of Arabidopsis thaliana to exogenous application of pipecolic acid

2018-06-04 | E-MTAB-6243 | ExpressionAtlas

A retrospective analysis comparing metagenomic next-generation sequencing with conventional microbiology testing for the identification of pathogens in patients with severe infections

Project description:mNGS

| PRJEB87803 | ENA

Project description:mNGS

| PRJNA760800 | ENA

Transcription targets of ASYMMETRIC LEAVES 2 (AS2), KANADI1 (KAN), REVOLUTA (REV) and SHOOT MERISTEMLESS (STM) genes

Project description:Dexamethasone applied to WT, GR-AS2, GR-KAN1, GR-REV and GR-STM seedlings and expression measured at 0, 30, 60 and 120 minutes after Dex application. SRA Series SRP051213 BioProject PRJNA258547. All reps are bio reps. Expression values are geometric normalized FPKM values from Tophat/Cufflinks reads and mappings.

2016-07-01 | E-GEOD-70796 | biostudies-arrayexpress

A post-processing algorithm for miRNA microarray data

Project description:One of the main disadvantages of using DNA microarrays for miRNA expression profiling is inability of adequate comparison of expression values across different miRNAs. This leads to a large amount of miRNAs with high scores which are actually not expressed in examined samples, i.e. false positives. We propose a post-processing algorithm which performs scoring of miRNAs in the results of microarray analysis based on expression values, time of discovery of miRNA represented by MIMAT accession number and correlation level between the expressions of miRNA and corresponding pre-miRNA in considered samples. The algorithm was successfully validated by the comparison of the results of its application to miRNA microarray breast tumor samples with publicly available miRNA-seq breast tumor data.

2019-10-04 | GSE138411 | GEO

custom mNGS

Project description:custom mNGS

| PRJEB42592 | ENA